Less than half of primary care providers refer patients with any degree of hematuria for urological evaluation.
The test displayed an overall high sensitivity for detecting bladder tumors.
Men at high-risk of bladder cancer were the most likely to be referred to urologists.
Researchers find rates lower than those observed in most clinical trials.
Screened patients were more likely to die from other smoking-related malignancies.
Levels of CEA and CA 19-9 were significantly higher in patients with tumor recurrence and/or progression.
Greater effects were seen in women with UTI, according to researchers.
Patients who experienced recurrence had a higher ratio than those who did not.
Use of the medications was associated with a significant 39% decreased risk of tumor recurrence after surgery.
Men who reported having severe lower urinary tract symptoms (LUTS) had a 64% increased risk of the malignancy compared with those who reported no LUTS.
Research raises concern about the simultaneous use of chemotherapy and fish oil.
For every 5 kg/m2 increase in BMI, the risk of bladder cancer rose 4.2%.
Daniel Canter, M.D., discusses narrow-band imaging (NBI) for visualization of bladder cancer.
Adjuvant chemotherapy is associated with better survival among patients with advanced nonmetastatic bladder cancer.
It has implications for treatment decisions and prognosis.
In a phase 2 trial, 72% of patients with high-grade clinical nonmuscle-invasive bladder cancer had a complete response at 3 months.
Researchers found elevated familial risks for testicular, prostate, bladder, and kidney cancers.
Risk factors include male gender, distant disease, increasing age, race/ethnicity
In a Canadian study, long wait times before a first urologist visit was associated with a 29% higher risk of death after radical cystectomy.
Smoking pot decreased the likelihood of the malignancy by 45%, whereas smoking tobacco only increased the likelihood by 52%.
Patients aged 70 and older are less likely than younger patients to receive post-cystectomy treatment, despite survival benefit
In community practice, overall rate of compliance with AUA Best Practices is less than 60 percent
Study of patients with muscle-invasive bladder cancer documents a particularly large increase in the use of neoadjuvant chemotherapy.
In a small randomized trial, functional and oncologic results did not differ significantly between the 2 approaches
These include patients with positive lymph nodes and surgical margins after cystectomy.
Transurethral resection of bladder tumor can cause cancer cells to be infused into the bloodstream.
Recurrence-free survival was 66 percent at five years for patients with bladder cancer who had laparoscopic radical cystectomy.
NBI visualized non-muscle-invasive bladder cancer lesions in 17% more patients and 24% more tumors than white light.
High serum levels of vitamin D may have a protective effect against bladder cancer.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)